Ignite Creation Date:
2024-05-05 @ 10:20 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01082887
Status:
TERMINATED
Last Update Posted:
2016-08-08
First Post:
2010-03-08
Brief Title:
A Study of Immunotherapy With TIL Tumor Infiltrating Lymphocytes in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus Ad-IFNg in Patients With Stage IIIc or Stage IV Metastatic Melanoma AJCCProtocol TIL-Ad-INFg
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Organization Data
Organization:
Nantes University Hospital
Class:
OTHER
Study ID:
BRD0905-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nantes University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None